Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
20.6M
-
Shares change
-
+538K
-
Total reported value, excl. options
-
$284M
-
Value change
-
+$4.47M
-
Number of buys
-
44
-
Number of sells
-
-26
-
Price
-
$13.78
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2020
81 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q3 2020.
TransMedics Group, Inc. - Common Stock (TMDX) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.6M shares
of 33.9M outstanding shares and own 60.65% of the company stock.
Largest 10 shareholders include FMR LLC (4.07M shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3.5M shares), BlackRock Inc. (1.57M shares), CREDIT SUISSE AG/ (1.5M shares), Sandhill Capital Partners LLC (1.15M shares), VANGUARD GROUP INC (1.13M shares), MACQUARIE GROUP LTD (745K shares), FEDERATED HERMES, INC. (713K shares), EMERALD ADVISERS, LLC (651K shares), and EMERALD MUTUAL FUND ADVISERS TRUST (608K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.